Al's Comment:

 This is a very interesting new type of immunotherapy for newly diagnosed Glioblastoma.  First, they remove the tumor, and enhance the sample and kill the tumor cells in the sample, then implant it back into the stomach in a biodiffusion chamber which is removed in 2-3 days, then you continue on with the standard therapy/ The idea is to stimulate an immune response against the tumor.    There is a chance of getting a placebo.  The problem is you have very little time to decide - the decision to enter the trial has to be done before your first surgery and you have to be close to a participating center. 


Posted on: 12/08/2023

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!